Comparing Mortality Risk Predictive Ability of Different Scoring Systems in Cirrhotic Patients with Bacteremia
Table 1
Baseline characteristics of cirrhotic patients with bacteremia (n = 127).
Characteristics
All (n = 127)
Nonsurvivors (n = 41)
Survivors (n = 86)
value
Age, y, mean ± SD
56.1 ± 12.5
56.1 ± 13.1
56.1 ± 12.3
1.00
Male, n (%)
98 (77.2)
32 (78.0)
66 (76.7)
1.00
Etiology of cirrhosis, n (%)
Alcohol
67 (52.8)
27 (65.9)
40 (46.5)
0.06
Viral hepatitis
45 (35.4)
10 (24.4)
35 (40.7)
0.08
Other
15 (11.8)
4 (9.8)
11 (12.8)
0.77
Child–Pugh classification, n (%)
A
7 (5.5)
0 (0)
7 (8.1)
B
42 (33.1)
9 (22.0)
33 (38.4)
C
78 (61.4)
32 (78.0)
46 (53.5)
MELD score, mean ± SD
25 ± 7
29 ± 5
22 ± 7
Comorbidities, n (%)
Diabetes mellitus
49 (38.6)
11 (26.8)
38 (44.2)
0.08
Hypertension
45 (35.4)
12 (29.3)
33 (38.4)
0.43
Malignancy
35 (27.6)
13 (31.7)
22 (25.6)
0.53
Laboratory results
Hemoglobin (g/dL), mean ± SD
10.1 ± 2.3
9.9 ± 2.6
10.2 ± 2.1
0.45
Leukocyte (×109/L), median (IQR)
10.1 (5.5–16.2)
12.5 (4.6–19.7)
9.6 (5.7–13.9)
0.25
Platelet (×109/L), median (IQR)
76 (44–120)
56 (40–124)
82 (53–121)
0.22
INR, median (IQR)
1.5 (1.3–1.8)
1.8 (1.4–2.2)
1.4(1.3–1.7)
Bilirubin (mg/dL), median (IQR)
4.9 (2.3–8.5)
6.3 (3.4–13.0)
3.9 (2.1–7.3)
Sodium (mmol/L), mean ± SD
130 ± 7
130 ± 7
129 ± 9
0.65
Creatinine (mg/dL), median (IQR)
1.4 (1.0–2.2)
1.8 (1.3–3.5)
1.3 (1.0–1.8)
CRP (mg/dL), median (IQR)
32.4 (9.1–91.6)
29.1 (9.9–103.3)
34 (7.9–86.2)
0.45
, SD: standard deviation. MELD: model for end-stage liver disease. IQR: interquartile range. INR: International Normalized Ratio. CRP: c-reactive protein.
